Eptifibatide Acetate

Eptifibatide Acetate 구조식 이미지
카스 번호:
148031-34-9
상품명:
Eptifibatide Acetate
동의어(영문):
INTEGRELIN;Eptifitide;EFTIFIBATIDE;Human Eptifibatide;EPTIFIBATIDE ACETATE;peptide eptifibatide acetate;Eptifibatide?Acetate impurity;MAP-LYS-GLY-ASP-TRP-PRO-CYS-NH2;Mpr-Har-Gly-Asp-Trp-Pro-Cys-NH2;EptifibatideAcetate impurity/Eptifibatide
CBNumber:
CB7416565
분자식:
C35H49N11O9S2
포뮬러 무게:
831.96
MOL 파일:
148031-34-9.mol

Eptifibatide Acetate 속성

녹는점
>220°C (dec.)
저장 조건
Refrigerator
용해도
DMSO(약간 용해됨), 메탄올(약간 용해됨), 물(약간 용해됨)
물리적 상태
고체
물리적 상태
단단한 모양
색상
흰색에서 황백색까지
InChIKey
CZKPOZZJODAYPZ-ITVGJGJRNA-N
SMILES
N12CCC[C@H]1C(=O)N[C@@H](CSSCCC(=O)N[C@@H](CCCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1C3C=CC=CC=3NC=1)C2=O)C(N)=O |&1:4,8,17,33,41,r|
CAS 데이터베이스
148031-34-9(CAS DataBase Reference)

안전

Eptifibatide Acetate C화학적 특성, 용도, 생산

Indications

Acute Coronary Syndrome (ACS)
INTEGRILIN? is indicated to decrease the rate of a combined endpoint of death or new myocardial infarction (MI) in patients with ACS (unstable angina [UA]/non-ST-elevation myocardial infarction [NSTEMI]), including patients who are to be managed medically and those undergoing percutaneous coronary intervention (PCI).
Percutaneous Coronary Intervention (PCI)
INTEGRILIN is indicated to decrease the rate of a combined endpoint of death, new MI, or need for urgent intervention in patients undergoing PCI, including those undergoing intracoronary stenting.

주요 응용

Eptifibatide is a cyclic heptapeptide containing 6 amino acids and 1 mercaptopropionyl (des-amino cysteinyl) residue. An interchain disulfide bridge is formed between the cysteine amide and the mercaptopropionyl moieties. Chemically it is N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-Llysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide, cyclic (1→6)-disulfide. Eptifibatide binds to the platelet receptor glycoprotein (GP) IIb/IIIa of human platelets and inhibits platelet aggregation.
The eptifibatide peptide is produced by solution-phase peptide synthesis, and is purified by preparative reverse-phase liquid chromatography and lyophilized. The structural formula is:

Structure of Eptifibatide

Dosage forms

Before infusion of INTEGRILIN, the following laboratory tests should be performed to identify pre-existing hemostatic abnormalities: hematocrit or hemoglobin, platelet count, serum creatinine, and PT/aPTT. In patients undergoing PCI, the activated clotting time (ACT) should also be measured.
The activated partial thromboplastin time (aPTT) should be maintained between 50 and 70 seconds unless PCI is to be performed. In patients treated with heparin, bleeding can be minimized by close monitoring of the aPTT and ACT.

Eptifibatide Acetate 준비 용품 및 원자재

원자재

준비 용품


Eptifibatide Acetate 공급 업체

글로벌( 317)공급 업체
공급자 전화 이메일 국가 제품 수 이점
Cellmano Biotech Limited
0551-65326643 18156095617
info@cellmano.com China 995 58
AFINE CHEMICALS LIMITED
+86-0571-85134551
sales@afinechem.com China 15225 58
Chengdu Youngshe Chemical Co., Ltd.
+8618108235634
Cecilia@youngshechem.com China 2345 58
Changsha MOL Changes Biotechnology Co., Ltd.
+8619375158599
info@molchanges.com China 5220 58
Hebei Jiafan Trading Company Limited
+86-15354498258
sales01@jiafan88.com China 133 58
Sinoway Industrial co., ltd.
0592-5800732; +8613806035118
xie@china-sinoway.com China 1000 58
Zibo Hangyu Biotechnology Development Co., Ltd
+86-0533-2185556 +8615965530500
nickzhang@hangyubiotech.com China 10987 58
Nantong Guangyuan Chemicl Co,Ltd
+undefined17712220823
admin@guyunchem.com China 615 58
Shaanxi TNJONE Pharmaceutical Co., Ltd
+86-17396673057
linda@tnjone.com China 1143 58
American HealthyMorph LLC
+85269498027
nancyyuan133@163.com China 169 58

Copyright 2019 © ChemicalBook. All rights reserved